Eurasia Review op-ed asks if GLP-1 success distracts from obesity's root causes
The writer credits semaglutide and tirzepatide with real results, but argues medicine risks treating an environmental problem with lifelong medication.
Recap by typeshit. Full story at Eurasia Review.